Roth Capital Starts Global Blood Therapeutics (GBT) at Buy, PT $47

November 1, 2016 8:31 AM EDT
Get Alerts GBT Hot Sheet
Price: $16.75 +0.60%

Rating Summary:
    7 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade GBT Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Roth Capital initiated coverage on Global Blood Therapeutics (NASDAQ: GBT) with a Buy rating and a price target of $47.00.

For an analyst ratings summary and ratings history on Global Blood Therapeutics click here. For more ratings news on Global Blood Therapeutics click here.

Shares of Global Blood Therapeutics closed at $17.45 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot New Coverage, New Coverage

Related Entities

Roth Capital

Add Your Comment